APA-viite

Sümbül, A. T., Dişel, U., Sezgin, N., Sezer, A., Köse, F., Beşen, A. A., . . . Özyılkan, Ö. (2014). Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment? International Scientific Literature, Inc.

Chicago-tyylinen lähdeviittaus

Sümbül, Ahmet Taner, Umut Dişel, Nurzen Sezgin, Ahmet Sezer, Fatih Köse, Ali Ayberk Beşen, Zehra Sümbül, Hüseyin Abalı, ja Özgür Özyılkan. Can Serial Monitoring of Serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) Levels Have Predictive Role During Bevacizumab Treatment? International Scientific Literature, Inc, 2014.

MLA-viite

Sümbül, Ahmet Taner, et al. Can Serial Monitoring of Serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) Levels Have Predictive Role During Bevacizumab Treatment? International Scientific Literature, Inc, 2014.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.